Azacytidine as a novel agent in the treatment of acute lymphoblastic leukemia.
Paulson
Kristjan
K
Kumar
Rajat
R
Ahsanuddin
Arshad
A
Seftel
Matthew D
MD
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001374:Azacitidine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010198:Pancytopenia / Q000139:chemically induced / Q000517:prevention & control*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D011379:Prognosis
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D001374:Azacitidine